Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.
NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.
A protein synthesis routes.
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Prevalence and severity of anxiety, stress, and depression in long COVID among adults in Barcelona.
Rethinking Optimal Immunogens to Face SARS-CoV-2 Evolution Through Vaccination.